期刊文献+

细胞因子在实验性肝纤维化中动态变化及其意义 被引量:3

The dynamic change of cytokines in experimental hepatic fibrosis and its significance
下载PDF
导出
摘要 目的:探讨细胞因子TGF-β1、IL-4和IFN-γ在肝纤维化形成中变化及意义。方法:采用二硝基亚硝胺(DMN)诱导大鼠肝纤维化模型,细胞生物法测定血清转化生长因子β1(TGF-β1),双抗夹心ELISA法测定血清白细胞介素4(IL-4),肿瘤坏死因子α(TNF-α)和γ-干扰素(IFN-γ),同时进行肝组织学检查和羟脯氨酸(Hyp)测定。结果:TGF-β1、IL-4和IFN-γ在肝纤维化中均是逐步升高,TNF-γ在肝纤维化中前期升高,后期降低;TGF-β1、IL-4和IFN-γ与肝纤维化组织Hyp的相关性较好,r分别为0.71,0.52,和0.62。结论:TGF-β1、IL-4、IFN-γ、TNF-α参与肝纤维化发生的细胞因子网络的调节。 Objective: To study the dynamic change of transform growth factor β1(TCF-β1) .interleukin 4(IL-4), tumor necrosis factor α(TNF-α) and gamma-interferon( IFN-γ) in experimental hepatic fibrosis formation and its significance. Methods: Dimethylnitrosmine (DMN) was used to produce a SD rat model. Serum content of TGF-β1 was examined with cell biology method, and serum content of three another cytokines, including IL-4, TNF-α and IFN-γ with double antibody ELISA method. Liver sections were stained with HE,Masson's trichome and Picric acid-Sirus red stain,respectively. Liver hydroxyproline (Hyp) content was detected. Results: TGF-β1, IL-4 and IFN-γ ascended gradually in the course of the development of hepatic fibrosis. TNF-α ascended in the early stage and descended in the later stage. There was better correlation between the contents of TGF-β1 , IL-4, IFN-γ and Hyp. The coefficient 'r' of these cytokines was 0.71,0.52,and 0.62. Conclusions:The results suggested that the four cytokines had played on important role in the regulation of hepatic fibrosis formation.
出处 《中国民康医学》 2004年第1期1-3,共3页 Medical Journal of Chinese People’s Health
关键词 细胞因子 肝纤维化 动态变化 结缔组织 血清转化生长因子Β1 TGF-Β1 TGF-β1 IL-4 IFN-γ TNF-α hepatic fibrosis
  • 相关文献

参考文献5

二级参考文献41

  • 1王要军,孙自勤.肝细胞与肝纤维化[J].前卫医学情报,1995,11(1):4-5. 被引量:4
  • 2王要军,孙自勤.肝窦内皮细胞与肝纤维化[J].临床肝胆病杂志,1996,12(3):115-117. 被引量:17
  • 3[1]Weiner FR, Giambrone MA, Czaja MJ, et al. [J].Hepatology, 1990,11(1): 111-117.
  • 4[2]Murawaki Y, Mishimura Y, Ikuta Y, et al. [J ]. J Gastroenterol Hepatol, 1998,13(7) :680-684.
  • 5[3]Nelson DR, Gonzalez RP, Qian K, et al. [J]. J Viral Hepatol, 1997,4( 1 ) :29-35.
  • 6[4]Carcia ER, Irauern MJ, Fontana L. [J]. Hepatology,1999,29(3) :960-970.
  • 7[5]Tiggelman AM, Linthorst C, Boers W, et al. [J]. J Hepatol, 1997,26(6): 1220-1228.
  • 8[6]Ikura Y,Morimoto H,Ogami M,et al. [J]. J Gastroenterol, 1997,32(4) :496-501.
  • 9[7]Isbrucker KA, Peterson TC. [J]. Toxicol Appl Pharmacol, 1998,149( 1 ): 120-126.
  • 10[8]Bachem MG, Sell KM,Melchior B,et al. [J]. Hepatology, 1992,16(21 Pt 2): 180A.

共引文献14060

同被引文献37

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部